Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

5 Years Follow-up of the Study: "Pharmacogenetics in Depressed Patients With Specific Focus on Difficult-to-treat Depresssion, Suicide Attempt and CYP2D6"

NCT07078227 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT07078227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07078227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
5 Years Follow-up of the Study: "Pharmacogenetics in Depressed Patients With Specific Focus on Difficult-to-treat Depresssion, Suicide Attempt and CYP2D6"
Lead sponsor
Region Skane
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2025
Completion date
December 31, 2026
Enrollment
415 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anhedonia, cyp2d6 polymorphism, depression, personality disorders, psychiatric diagnosis, suicide, attempted